139
Participants
Start Date
July 7, 2020
Primary Completion Date
November 18, 2024
Study Completion Date
November 18, 2024
LY3372993
Administered IV or SC.
Placebo
Administered IV or SC.
Progressive Medical Research, Port Orange
Charter Research, The Villages
Synexus Clinical Research US, Inc., The Villages
Accel Research Sites- Clinical Research Unit, DeLand
MD Clinical, Hallandale
IMIC, Inc., Miami
Covance Dallas, Dallas
Altasciences Clinical Los Angeles, Inc, Cypress
Collaborative Neuroscience Research, LLC, Long Beach
Ppd Development, Orlando
Oita University Hospital, Yufu
The University of Tokyo Hospital, Bunkyo-ku
Clinical Research Hospital Tokyo, Shinjuku-ku
Eli Lilly and Company
INDUSTRY